Fresenius | FRE - Чистый доход





Чистый доход Изменить Дата
Akzo Nobel EUR 93M 505M 2026-03
Alcon AG USD 189M 28M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
BASF EUR 927M 367M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Beiersdorf EUR 387M 165M 2025-12
DaVita Healthcare Partners USD 197.53M 36.69M 2026-03
Demant DKK 427M 690M 2025-12
E.ON EUR 2.23B 1.41B 2026-03
Essilor EUR 928M 459M 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 118M 209M 2026-03
Getinge SEK 839M 177M 2026-06
Givaudan CHF 479M 113M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GN Store Nord DKK -955M 1.3B 2026-03
GRIFOLS EUR 73M 25.25M 2026-03
Hikma Pharmaceutical USD 164M 45M 2025-12
Lonza CHF 426M 119M 2025-06
Merck EUR 659M 340M 2026-03
Novartis USD 3.16B 747M 2026-03
Philips EUR 151M 244M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
RWE EUR 20M 811M 2026-03
Sanofi EUR 1.61B 2.42B 2026-03
Smith & Nephew USD 293M 79M 2025-12